Andrea Loreto

Dr. Andrea Loreto


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Mootaz SalmanMootaz Salman
Mootaz Salman
Zaid Al-ObaidiZaid Al-Obaidi
Zaid Al-Obaidi
Philip KitchenPhilip Kitchen
Philip Kitchen
ALAndrea Loreto
Andrea Loreto
Roslyn BillRoslyn Bill
Roslyn Bill
RWRichard Wade-Martins
Richard Wade-Martins
Neurodegenerative diseases (NDs) including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease are incurable and affect millions of people worldwide. The development of treatments for this unmet clinical need is a major global research challenge. Computer-aided drug design (CADD) methods minimize the huge number of ligands that could be screened in biological assays, reducing the cost, time, and effort required to develop new drugs. In this review, we provide an introduction to CADD and examine the progress in applying CADD and other molecular docking studies to NDs. We provide an updated overview of potential therapeutic targets for various NDs and discuss some of the advantages and disadvantages of these tools.